Industry News - BioPharm International

ADVERTISEMENT

Industry News
The latest news about industry suppliers, business activities, people.

Sun Pharma to Acquire Ranbaxy

April 7, 2014

Sun Pharma acquisition of Ranbaxy Laboratories will create the fifth-largest specialty generics company in the world.

A New Plant Biotech Approach for Efficient Production of Pharmaceutical Compound

April 7, 2014

European scientists have discovered a method to improve the efficiency of the pharmaceutical production through plant biotechnology.

Lilly To Release Data Targeting Key Cancer Pathways At AACR 2014

April 7, 2014

Eli Lilly will present early-stage data regarding cancer therapies at AACR 2014.

Genzyme to Resubmit Lemtrada Application for FDA Review

April 7, 2014

Sanofi and Genzyme to resubmit FDA application for approval of Lemtrada, for the treatment of relapsing forms of multiple sclerosis.

Recurrent Head and Neck Tumors Could be Vulnerable to Cancer Drug

April 7, 2014

New research finds that recurrent head and neck tumors have gene mutations that could be vulnerable to the cancer drug dasatinib.

Regulatory Compliance Associates Expands into Poland

March 28, 2014

RCA opens a new office in Warsaw, Poland.

Vetter Implements New Serialization Services

March 28, 2014

Vetter launches new serialization process to support track-and-trace efforts.

XstalBio Launches Vaccine Analysis Service

March 24, 2014

XstalBio Analytics' approach to vaccine analysis and formulation is aimed at understanding the antigen– adjuvant interaction.

FDA approves Novartis' Xolair for Rare Skin Disease

March 24, 2014

FDA approves Xolair (omalizumab) for the treatment of a rare skin disease known as chronic idiopathic urticarial.

ADVERTISEMENT

ADVERTISEMENT

Click here